These conflicting findings may suggest a differential pattern of SIRT3 expression in prostate cancer tissues and cells, which may depend on the cell type, tumor stage or grade, and genetic differences in the prostate cancer tissues or cells. Here, SIRT3 is linked to prostate carcinoma.